Evidence map›Paper›PMID 35378141›Full record

ArticleThe Journal of infection2022

Decrease of carbapenemase-producing Enterobacteriaceae incidence during the first year of the COVID-19 pandemic.

Clarisse Duverger, Catherine Monteil, Valérie Souyri, Sandra Fournier, AP-HP Infection prevention and control teams

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of infection, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Incidence of colonization and infection with carbapenemase-producing Enterobacterales in Toronto and Peel Region, Ontario, 2007-2024.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Clarisse DuvergerAssistance Publique-Hôpitaux de Paris, Central Infection Prevention and Control Team, 3 avenue Victoria, Paris 75004, France. Electronic address: clarisse.duverger@aphp.fr.
Catherine MonteilAssistance Publique-Hôpitaux de Paris, Central Infection Prevention and Control Team, 3 avenue Victoria, Paris 75004, France.
Valérie SouyriAssistance Publique-Hôpitaux de Paris, Central Infection Prevention and Control Team, 3 avenue Victoria, Paris 75004, France.
Sandra FournierAssistance Publique-Hôpitaux de Paris, Central Infection Prevention and Control Team, 3 avenue Victoria, Paris 75004, France.
AP-HP Infection prevention and control teamsAssistance Publique-Hôpitaux de Paris, Central Infection Prevention and Control Team, 3 avenue Victoria, Paris 75004, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carbapenem-Resistant EnterobacteriaceaeCOVID-19Enterobacteriaceae InfectionsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesEnterobacteriaceaeHumansIncidenceMicrobial Sensitivity TestsPandemicsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenemase-producing EnterobacteriaceaeCOVID-19Healthcare-associated infectionInfection controlSARS-CoV-2

Identifiers

PMID35378141
PMCPMC8971063

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.